Work

White Paper
How Gini scores can help you differentiate payers
Payers act as gatekeepers who decide which drugs to cover and how to cover them. Each payer has their own specific rules for different drugs, which they apply and enforce in unique ways. Learn how applying a Gini score can help you make sense of this variability and guide strategic decisions to achieve your access goals.
Case Study
How does a commitment to training transform your Pull Through tool utilization?
Learn how Payer Sciences helps clients improve the effectiveness of their sales force by maximizing the usage and impact of the Pull Through Optimizer through education and training.
Case Study
How do you communicate your product's economic value?
Learn how Payer Sciences translated health economic data into clear and compelling messages. Read on to see how a FDAMA 114 presentation resonated across the IDN ecosystem.
Case Study
How do you cost-effectively amplify your message?
Learn how Payer Sciences helped a client keep messaging top of mind with consistent and frequent exposure wherever key decision-makers consumed media. Read on to see how the results spoke for themselves.
OPGs-banner 1x.gif
Data Story
When Prescribing Decisions Come Under New Management
The forming of physicians and other healthcare stakeholders into organized provider groups or OPGs is changing the way prescribing decisions are made. Learn how dramatically the landscape has changed, and what pharmaceutical marketers need to know to optimize strategies and tactics for their brands. Hint: The answers lie in the data.
case studies web banners Rebating_L1.png
White Paper
Do you know when rebating loses its cost-effectiveness?
Payer contracting models traditionally rely on a top-down analysis which leaves one important question unanswered: How will a change in coverage position impact net revenue on a prescriber-by-prescriber basis? Learn about how our bottom-up model answers that question and more.
PayerSciences Case Study - Confronting Category Restrictions.jpg
Case Study
How PTO helped grow volume by 21%
Pull through is often disregarded in highly restrictive categories. Read about how we helped our client correct coverage misperceptions and increase volume.
PayerSciences PerSpectives - Reengineering pricing.jpg
White Paper
Are you relying on only one study to set pricing?
Setting a new specialty drug price is a daunting, high-stakes game. We think it’s time to reengineer the pricing decision process to include a variety of inputs. Learn more about how our disciplined approach helped our client establish an optimal price.
case studies web banners Finding Elusive Stakeholders_L1.jpg
Case Study
How do you find gene therapy stakeholders who are as ultra-rare as the diseases they treat?
Learn how Payer Sciences used our market access experience and network to help a client locate elusive gene therapy stakeholders for critical market research.
case studies web banners CoPay analysis_L1.jpg
Case Study
How do you develop a copay offset program that ensures patient access without breaking the bank?
Read about how we helped a client calibrate and construct a copay offset program that ensured patient access without breaking the bank.
perspectives_access barriers_L2.jpg
White Paper
Do access barriers always suppress demand?
For each prior authorization criterion a payer creates, your forecasted revenue bucket can spring a leak. Point of care staff armed with the right tools can better navigate obstacles and stop the leaks. Learn the 4 steps to effective access navigation.
growing your brand_web_L4.jpg
Case Study
How do you harness HCP-specific coverage to prioritize sales resources?
Before investing resources in brand share growth, it is crucial to gain a deep understanding of unique coverage environments at the individual HCP level. Learn how we can help.
case studies web banners Predicting_L1_v1.jpg
Case Study
How do you anticipate payer coverage when launching in uncharted territory?
Read about how we helped a client by taking a unique approach to market segmentation that helped prioritize payers with the highest potential to restrict access and inform more tailored messaging.
work images_23.jpg
Case Study
When all things seem equal, how do you prove your worth?
Read about how we helped a product vulnerable to generic substitution secure unrestricted access at launch, achieving its 90% coverage goal.
how-data-directed-messaging-grew-market-share.png
Case Study
How data-directed messaging grew market share by 18%
Learn how, even with good coverage, relevant prescriber-specific messages can lead to increased sales representative confidence, increased HCP confidence, and 18% greater market share growth.
work images_2.jpg
White Paper
Who is the ultimate influencer: Payers or IDNs?
Today, between 40% and 70% of healthcare providers are affiliated with an IDN or a provider network. But how do you know which to target? Learn how the right data analytics can disentangle the sources of influence to provide direction.